
Organization · Private Equity
Geneva Private Equity
Geneva Private Equity focuses on late-stage MedTech and healthcare ventures, providing strategic capital and expertise to drive growth.
Overview
What Geneva Private Equity does
What Geneva Private Equity is
Geneva Private Equity focuses on late-stage MedTech and healthcare ventures, providing strategic capital and expertise to drive growth.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Structured capabilities
- Funder
- Last reviewed
- April 8, 2026
Official channels
Find Geneva Private Equity elsewhere
Open the official website or a supported primary organization account.
Capability profile
Geneva Private Equity as a funder
Investment thesis
Geneva Private Equity focuses on post-clinical medical technology companies, emphasizing commercialization and distribution-driven growth.
Focus narrative
Geneva Private Equity invests in medical technology companies that are at critical inflection points, specifically those that have established regulatory pathways and validated core products. The firm emphasizes hands-on collaboration in commercialization, distribution, and operational execution.
Value beyond capital
Geneva Private Equity adds value through hands-on collaboration in commercialization, distribution, and operational execution, helping portfolio companies scale effectively.
Focus and fit
- Stages
- Growth Equity
- Sectors
- Healthcare · Medical Devices · Diagnostics
- Regions
- United States
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Geneva Private Equity has invested in several notable companies, including Clarity Diagnostics, an exclusive U.S. commercialization platform for advanced medical diagnostic products; Clarity Labs, focusing on advanced medical diagnostic products with over $12M+ ARR; ICHORtec GmbH, specializing in innovative molecular diagnostics; EKGx, a portable 12-lead EKG platform; and NXXIM, an enterprise imaging platform unifying medical imaging across specialties.
Connected ecosystem
Continue from Geneva Private Equity
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Common questions
What to know about Geneva Private Equity
Upseed classifies Geneva Private Equity under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 8, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.